中国心脏起搏与心电生理杂志

参考文献

[1] DENEKE T, KUTYIFA V, HINDRICKS G, et al. Pre-and post-procedural cardiac imaging(computed tomography and magnetic resonance imaging)in electrophysiology:a clinical consensus statement of the European Heart Rhythm Association and European Association of Cardiovascular Imaging of the European Society of Cardiology[J]. Europace, 2024, 26(5):euae108.

[2] KITKUNGVAN D, NABI F, GHOSN M G, et al. Detection of LA and LAA thrombus by CMR in patients referred for pulmonary vein isolation[J]. JACC Cardiovasc Imaging,2016, 9(7):809.

[3] MARROUCHE N F, WILBER D, HINDRICKS G, et al.Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation:the DECAAF study[J]. JAMA, 2014, 311(5):498.

[4] MARROUCHE N F, WAZNI O, MCGANN C, et al. Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation:the DECAAFⅡrandomized clinical trial[J]. JAMA, 2022, 327(23):2296.

[5] NAKATANI Y, SRIDI-CHENITI S, CHENITI G, et al.Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation[J]. Europace, 2021, 23(11):1767.

[6] MAHAJAN R, KUKLIK P, GROVER S, et al. Cardiovascular magnetic resonance of total and atrial pericardial adipose tissue:a validation study and development of a 3 dimensional pericardial adipose tissue model[J]. J Cardiovasc Magn Reson,2013,15:73.

[7] KATO S, FOPPA M, ROUJOL S, et al. Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation[J]. Int J Cardiol, 2016, 203:848.

[8] SUKSARANJIT P, AKOUM N, KHOLMOVSKI E G, et al. Incidental LV LGE on CMR imaging in atrial fibrillation predicts recurrence after ablation therapy[J]. JACC Cardiovasc Imaging, 2015, 8(7):793.

[9] NEILAN T G, MONGEON F P, SHAH R V, et al.Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation[J].JACC Cardiovasc Imaging, 2014, 7(1):1.

[10] BERTAGLIA E, BELLA P D, TONDO C, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation:results from the CartoMerge Italian Registry[J]. Europace, 2009, 11(8):1004.

[11] FINLAY M C, HUNTER R J, BAKER V, et al. A randomised comparison of Cartomerge vs. NavX fusion in the catheter ablation of atrial fibrillation:the CAVERN Trial[J].J Interv Card Electrophysiol, 2012, 33(2):161.

[12] DELLA BELLA P, FASSINI G, CIREDDU M, et al.Image integration-guided catheter ablation of atrial fibrillation:a prospective randomized study[J]. J Cardiovasc Electrophysiol, 2009, 20(3):258.

[13] CAPONI D, CORLETO A, SCAGLIONE M, et al.Ablation of atrial fibrillation:does the addition of threedimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome? A randomized comparison of Carto-Merge vs. Carto-XP threedimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation[J]. Europace, 2010, 12(8):1098.

[14] MAMMADLI A, DEMIRTOLA A I, DIKER E. Impact of image integration on clinical and procedural outcomes of radiofrequency catheter ablation of atrial fibrillation:A metaanalysis of randomized controlled trials[J]. J Arrhythm,2021, 37(3):550.

[15] CALKINS H, HINDRICKS G, CAPPATO R, et al. 2017HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Europace, 2018, 20(1):e1.

[16] WEINSAFT J W, KIM H W, SHAH D J, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction[J]. J Am Coll Cardiol, 2008, 52(2):148.

[17] WEINSAFT J W, KIM R J, ROSS M, et al. Contrastenhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus[J]. JACC Cardiovasc Imaging, 2009, 2(8):969.

[18] WIJNMAALEN A P, VAN DER GEEST R J, VAN HULS VAN TAXIS C F, et al. Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias:real-time image integration and reversed registration[J]. Eur Heart J, 2011,32(1):104.

[19] COCHET H, KOMATSU Y, SACHER F, et al. Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation:a pilot study[J]. J Cardiovasc Electrophysiol, 2013, 24(4):419.

[20] GHANNAM M, COCHET H, JAIS P, et al. Correlation between computer tomography-derived scar topography and critical ablation sites in postinfarction ventricular tachycardia[J]. J Cardiovasc Electrophysiol, 2018, 29(3):438.

[21] ESPOSITO A, PALMISANO A, ANTUNES S, et al.Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate:relationship between CT-segmented scar and electroanatomic mapping[J]. JACC Cardiovasc Imaging, 2016, 9(7):822.

[22] YAMASHITA S, SACHER F, HOOKS D A, et al.Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia[J]. Heart Rhythm, 2017, 14(2):155.

[23] SOTO-IGLESIAS D, PENELA D, JáUREGUI B, et al.Cardiac magnetic resonance-guided ventricular tachycardia substrate ablation[J]. JACC Clin Electrophysiol, 2020, 6(4):436.

[24] BERTE B, COCHET H, DANG L, et al. Image-guided ablation of scar-related ventricular tachycardia:towards a shorter and more predictable procedure[J]. J Interv Card Electrophysiol, 2020, 59(3):535.

[25] SHANBHAG S M, GREVE A M, ASPELUND T, et al.Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults[J]. Eur Heart J, 2019, 40(6):529.

[26] ZGHAIB T, IPEK E G, HANSFORD R, et al. Standard ablation versus magnetic resonance imaging-guided ablation in the treatment of ventricular tachycardia[J]. Circ Arrhythm Electrophysiol, 2018, 11(1):e005973.

[27] NJEIM M, DESJARDINS B, BOGUN F. Multimodality imaging for guiding ep ablation procedures[J]. JACC Cardiovasc Imaging, 2016, 9(7):873.

[28] XIE S, DESJARDINS B, KUBALA M, et al. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy:Implications for ventricular tachycardia ablation[J]. Heart Rhythm, 2018, 15(7):987.

[29] ZGHAIB T, GHASABEH M A, ASSIS F R, et al. Regional strain by cardiac magnetic resonance imaging improves detection of right ventricular scar compared with late gadolinium enhancement on a multimodality scar evaluation in patients with arrhythmogenic right ventricular cardiomyopathy[J]. Circ Cardiovasc Imaging, 2018, 11(9):e007546.

[30] KOMATSU Y, JADIDI A, SACHER F, et al. Relationship between MDCT-imaged myocardial fat and ventricular tachycardia substrate in arrhythmogenic right ventricular cardiomyopathy[J]. J Am Heart Assoc, 2014, 3(4):e000935.

[31] VENLET J, TAO Q, DE GRAAF M A, et al. RV tissue heterogeneity on CT:A novel tool to identify the VT substrate in ARVC[J]. JACC Clin Electrophysiol, 2020, 6(9):1073.